🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the weight loss effect of lorcaserin...
Status
Completed
Location
Arena Pharmaceuticals, Inc.
Start Date
2007-12
Trial ID
NCT00603291
Treatments Being Tested
A Randomized Phase II study Comparing Lorcaserin versus Duloxetine for the ...
Status
Unknown
Location
Cancer Treatment Centers of America - Atlanta
Start Date
2019-06
Trial ID
NCT03812523
Treatments Being Tested
Heavy-drinking smokers, including those with alcohol use disorder (AUD), ar...
Status
Terminated
Location
The Mind Research Network
Start Date
2019-10-25
Trial ID
NCT04396847
Treatments Being Tested
In smokers who are motivated to stop smoking, treatment with lorcaserin com...
Status
Completed
Location
Pharmacology Research Institute
Start Date
2014-03
Trial ID
NCT02044874
Treatments Being Tested
The fixed-dose combination of naltrexone 8mg and bupropion 90mg extended-re...
Status
Completed
Location
Currax Pharmaceuticals
Start Date
2014-09
Trial ID
NCT06090461
The purpose of this study is to identify gene variants that increase risk o...
Status
Terminated
Location
Duke University Medical Center
Start Date
2018-05-24
Trial ID
NCT03011645
Treatments Being Tested
In the United States, 1.5 million people abuse cocaine leading to a host of...
Status
Withdrawn
Location
McLean Hospital
Start Date
2018-10-04
Trial ID
NCT03266939
Treatments Being Tested
The purpose of this study is to determine whether lorcaserin is effective f...
Status
Unknown
Location
VA Long Beach
Start Date
2014-01
Trial ID
NCT01962402
Treatments Being Tested
Study will evaluate the pharmacokinetics (PK), safety and tolerability of a...
Status
Completed
Location
Anaheim Clinical Trials
Start Date
2015-03
Trial ID
NCT02398669
Treatments Being Tested
The purpose of this study is to demonstrate the bioequivalence between lorc...
Status
Completed
Location
Worldwide Clinical Trials
Start Date
2018-08-07
Trial ID
NCT03627936
Treatments Being Tested